Takaaki Matsudo - Concepedia

Author

Takaaki Matsudo

Tokyo Medical University

Also Known As

TAKAAKI MATSUDO, Takaaki Matsudo

Publications

370

Citations

H-Index

Concepts

All Affiliations

Tokyo Medical University

About

Takaaki Matsudo is an author at Tokyo Medical University specializing in medicine, pathology, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	261
2	Gastroenterology	3	3	73
3	Natural Sciences	1	1	176
4	Cell Biology	1	1	176
5	Immunology	1	1	12

Takaaki Matsudo

Publications

341

Citations

H-Index

Page 1

	Year	Citations
Deregulation of miR‐92a expression is implicated in hepatocellular carcinoma development Masatoshi Shigoka, Akihiko Tsuchida, Takaaki Matsudo, Pathology International PathologyRobust BiomarkersTumor BiologyHcc PatientsTranscriptional Regulation	2010	176
Bacterial Contamination in Ascitic Fluid Is Associated With the Development of Clinically Relevant Pancreatic Fistula After Pancreatoduodenectomy Yuichi Nagakawa, Takaaki Matsudo, Yousuke Hijikata, Pancreas	2013	55
The VIO soft-coagulation system can prevent pancreatic fistula following pancreatectomy Yuichi Nagakawa, Akihiko Tsuchida, Hitoshi Saitô, Journal of Hepato-Biliary-Pancreatic Surgery Pancreatic CancerVio Soft-coagulation SystemGastroenterologyPancreatic SurgerySurgery	2008	30
p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction Kazuhiko Kasuya, Yuichi Nagakawa, Takaaki Matsudo, Journal of Hepato-Biliary-Pancreatic Surgery Simultaneous Double CancerPancreatic CancerBiliary TractBiliary CancerGastroenterology	2009	29
Why Does Postoperative Pancreatic Fistula Occur After Hand-sewn Parenchymal Closure and Staple Closure in Distal Pancreatectomy? Yuichi Nagakawa, Yosuke Hijikata, Hiroaki Osakabe, Surgical Laparoscopy Endoscopy & Percutaneous Techniques Stump NecrosisRemnant PancreasPancreatic Fluid CollectionGastroenterologyPancreatic Surgery	2018	14
GSTP1 as a potential predictive factor for adverse events associated with platinum‑based antitumor agent‑induced peripheral neuropathy Sou Katayanagi, Kenji Katsumata, Yasuharu Mori, Oncology Letters	2019	14
Combination therapy of gemcitabine or oral S-1 with the anti-VEGF monoclonal antibody bevacizumab for pancreatic neuroendocrine carcinoma Kazuhiko Kasuya, Yuichi Nagakawa, Minako Suzuki, Experimental and Therapeutic Medicine Pancreatic CancerBevacizumab MonotherapyMedicineImmunologyPharmacology	2012	12
Prospective Multicenter Phase II Study of Biweekly TAS-102 and Bevacizumab for Metastatic Colorectal Cancer Tetsuo Ishizaki, Junichi Mazaki, Masanobu Enomoto, Anticancer Research	2021	11

Page 1